Best Life Sciences Companies in Madrid, Spain
The 78 best Life Sciences companies in Madrid, Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Cellerix.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Madrid
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Cellerix Stem Cell Therapy for the treatment of gastroenterology, dermatology, and immune-based diseases | $78M | 199 mo ago | Acquired | 67 | — | 122 patents Adipose-derived mesenchymal stem cell therapies and related biomaterial delivery systems | — |
| 2 | MedLumics Developer of biological tissue imaging by using optical coherence tomography | $63M | 49 mo ago | Series E | 29 | — | 253 patents Intravascular optical imaging and laser ablation guidance using fiber‑based catheters | — |
| 3 | Veritas Intercontinental Provider of genomic services | $23M | 68 mo ago | Acquired | 43 | George Church Founder | — | — |
| 4 | Geniova Technologies Developer of clear aligner orthodontic system integrating archwire and 3D-printed components | $13M | 17 mo ago | Series B | — | — | 9 patents Patents concentrated in health & consumer products | — |
| 5 | Algenex Developer of recombinant biologics for animal and human health | $13M | 69 mo ago | Series B | 28 | — | 3 patents Rabbit hemorrhagic disease vaccines for veterinary immunization | — |
| 6 | Nuubo Provider of wearable cardiac monitoring system | $10M | 100 mo ago | Series B | 30 | — | — | — |
| 7 | NIMGenetics Diagnostic solutions based on microarray and next-generation sequencing technologies | $8M | 109 mo ago | Acquired | 97 | — | — | — |
| 8 | Amadix Provider of diagnostic tools to support personalized cancer treatment | $7M | 16 mo ago | Series A | 35 | Rocio Arroyo CEO | — | — |
| 9 | Be Levels Developer of nutritional supplements to enhance overall health and well-being | $7M | 20 mo ago | Series A | 11 | — | — | 1 job opening |
| 10 | MedicSen Mobile app to manage diabetes | $6M | 25 mo ago | Seed | 15 | — | — | — |
| 11 | Europa America Laboratorios Provider of clinical and genetic analysis services | $5M | 91 mo ago | Deadpooled | — | Fidel Lopez Cuesta Co-Founder & CEO | — | — |
| 12 | A4Cell Developer of tool for monitoring and studying alive single cell | $5M | 31 mo ago | Series B | 14 | Elena Rivas CEO | — | — |
| 13 | Marsi-Bionics Developer of robotic exoskeleton for children's mobility | $5M | 35 mo ago | Series A | 38 | — | 16 patents Modular exoskeleton support devices for assisted human movement and rehabilitation | 1 job opening · 1 award |
| 14 | InsulCloud Smart device for checking insulin adherence | $4M | 49 mo ago | Series A | 25 | — | 32 patents Smart monitoring systems for drug injection pens with universal sensor adapters | — |
| 15 | AptaTargets Provider of therapeutic solutions for ischemic diseases | $3M | 94 mo ago | Series A | 10 | Victor Manuel Gonzalez Muñoz Cofounder and Scientific Advisor | — | — |
| 16 | SpotLab Platform offering an AI powered solutions for biopharma research and diagnostics | $2M | 49 mo ago | Funding Raised | 23 | Miguel Oroz Founder & CEO | 7 patents Integrating digital imaging devices with optical instruments for sample acquisition. | 1 award |
| 17 | ALA Diagnostics Developer of invitro diagnostic kits for the detection of multiple sclerosis | $1M | 36 mo ago | Seed | — | Jose Ramon Montero Founder | — | — |
| 18 | Ownmed Innovation Developer of medical devices for ostomy care | $683K | 25 mo ago | Seed | — | Ana Zhang Founder & CEO | 9 patents Reflux-prevention devices for ostomy stoma care | 1 launch · 1 award |
| 19 | Evolufarma Marketing automation platform for pharmacies | $623K | 109 mo ago | Deadpooled | — | Luis Arimany Espanaque CEO | — | — |
| 20 | Leadartis Provider of protein engineering platform for multi-target therapeutic development | $242K | 73 mo ago | Seed | 6 | — | 25 patents Engineered trimeric antibody‑collagen fusion proteins for cancer immunotherapy | — |
| 21 | Biosearch Life Developer of nutritional probiotics and functional foods | $146K | 101 mo ago | Acquired | 150 | Jose Roset CEO & MD | — | — |
| 22 | Oxoprobics Biosciences Provider of microplate readers for research applications | $115K | 89 mo ago | Funding Raised | — | Juan Martin Co-Founder & CEO | — | — |
| 23 | Somax Systems A handheld ultrasound imaging devices | $114K | 83 mo ago | Funding Raised | — | David Laorden Co-Founder | — | — |
| 24 | Taniwa Solutions Platform for neurological evaluation to perform early detection of neurodegenerative issues | $110K | 128 mo ago | Funding Raised | 10 | Manuel Guillermo Fraga Castro Co-Founder & CFO | — | — |
| 25 | AURA Innovative Robotics Diagnostic tool for neurological and mental disorders | $110K | 107 mo ago | Funding Raised | 8 | Rafael Acebron Lopez Co-Founder | — | — |
| 26 | At-Biotech solution Provider of a software solution for life sciences research | $109K | 108 mo ago | Funding Raised | 10 | Aida Agea CEO | — | — |
| 27 | 2EyesVision Developer of portable technologies for multifocal correction before intraocular surgeries | $100K | 63 mo ago | Series A | 18 | Susana Marcos Co-founder 2EyesVision | — | 1 partnership |
Top 12 Life Sciences companies in Madrid
#1
Series A · Madrid, Community of Madrid · founded 2010 · 35 employees$6.9Mraised▾
Provider of diagnostic tools to support personalized cancer treatment. The company has developed prognostic, diagnostic, and predictive tests for lung cancer, colorectal cancer, and prostate cancer. Its colon cancer test ColoFast is a blood-based miRNA test for early detection of colon cancer. It is also developing DiagnoLung which is a blood-based ELISA test that measures the level of three protein biomarkers to screen high-risk patients for non-small-cell lung cancer.
- Feb 2025Venture Debt$15.6M
- Aug 2022Grant (prize money)$2.6M
- Jun 2021Grant (prize money)$3.4M
- Oct 2020Grant (prize money)$152.1K
#2
Series B · Madrid, Community of Madrid · founded 2014$13.5Mraised▾
Developer of clear aligner orthodontic system integrating archwire and 3D-printed components. The system combines archwire force with aligner invisibility. It uses 3D-designed and custom-made components. The system includes individually sectioned copings for controlled movement. Brackets direct movement by flexing the archwire. Attachments secure the coping to the tooth. Encapsulation protects the archwire for comfort.
- Jan 2025Series B$13.5M
#3
Series A · Madrid, Community of Madrid · founded 2020 · 11 employees$6.7Mraised▾
Developer of nutritional supplements to enhance overall health and well-being. The company's products, including be calm, triple magnesium, and creatine, are backed by scientific research and aim to promote relaxation, reduce anxiety, and enhance physical performance.
- Oct 2024Series A$6.7M
#4
Seed · Madrid, Community of Madrid · founded 2015 · 15 employees$5.5Mraised▾
MedicSen offers a mobile application that can monitor and predict future glucose levels and recommends meals, insulin doses and exercise to manage diabetes. The application can also automatically collect data from connected glucometers. The company is also developing Smart-patch for the administration of insulin without needles, that will take information from the App to personalize the treatment automatically according to the needs of the patient.
- Apr 2024Grant (prize money)$5.3M
- 2022Grant (prize money)—
- May 2020Grant (prize money)—
- Jan 2018Grant (prize money)$62K
#5
Series E · Madrid, Community of Madrid · founded 2009 · 29 employees$62.8Mraised▾
MedLumics is a developer of biological tissue imaging by using optical coherence tomography. It is using infrared light this imaging modality allows for noninvasively, sectional images of the inside of biological tissues with micrometer resolution. This is also known as a virtual biopsy. The technology platform MedLumics OCT is a point of care optical imaging solution for diagnosis. According to the company, it can also find application in the management of skin diseases. Its product, Nitid, a product for diagnostic imaging for the management of skin problems. The device weighs around 3kg is sold under CE by DermaLumics, a sister company focused on the dermatology market.
- Apr 2022Grant (prize money)$52.7K
- Oct 2020Series E$21.2M
- May 2019Grant (prize money)$2.8M
- Mar 2017Series B$36.9M
#6
Series B · Madrid, Community of Madrid · founded 2018 · 14 employees$5.4Mraised▾
Developer of tool for monitoring and studying alive single cell. The SPAchip Technology is used to study alive cell behavior, physiology, and information of cells. It is also used to analyze interactions among biomolecules and monitor individual cell responses over time.
- Nov 2023Series B$3.3M
- Apr 2022Grant (prize money)$747.2K
- Dec 2021Series A$1.4M
- Apr 2019Seed$728.7K
#7
Series A · Madrid, Community of Madrid · founded 2013 · 38 employees$4.9Mraised▾
Developer of robotic exoskeleton for children's mobility. It has developed lower body exoskeleton gear ranging from a single joint to full active orthosis from trunk to foot. The bionics feature controllable stiffness and this helps in personalizing therapy progress. The products are aimed at patients with neuromuscular diseases, spinal cord injuries, and more.
- Jul 2023Series A$4.9M
- Mar 2018Grant (prize money)$2M
- Jan 2018Grant (prize money)$2M
- Sep 2017Grant (prize money)$121.3K
#8
Seed · Madrid, Community of Madrid · founded 2021$682.9Kraised▾
Developer of medical devices for ostomy care. The company develops Ostofix is a revolutionary ostomy device for ostomized patients to manage waste material ensuring optimal comfort and functionality for patients.
- May 2024Seed$682.9K
#9
Acquired · Madrid, Community of Madrid · founded 2004 · 67 employees$78.5Mraised▾
Cellerix engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based diseases. Its products include Cx401, which is used for the treatment of complex perianal fistulas; and Cx501, a cell therapy product to be applied in the treatment of Epidermolysis Bullosa.
- Nov 2009Series C$40.5M
- Sep 2007Series B$38M
#10
Acquired · Madrid, Community of Madrid · founded 2014 · 43 employees$23.4Mraised▾
Veritas provides genomic services. The company provides genetic testing and genetic counseling services. The company offers a range of genomic testing services for health, newborn hereditary disease risk, cancer diagnosis, pharmacogenetics, and others.
- Sep 2020Series B$5.9M
#11
Series A · Madrid, Community of Madrid · founded 2014 · 25 employees$4.2Mraised▾
Smart device for checking insulin adherence
- May 2022Series A$4.2M
- Jul 2018Grant (prize money)$1.2M
- Nov 2016Grant (prize money)$1.1M
- Oct 2015Grant (prize money)$55K
#12
Seed · Madrid, Community of Madrid · founded 2019$1.2Mraised▾
Developer of invitro diagnostic kits for the detection of multiple sclerosis. The company offers a blood test that uses a patented recombinant protein as a diagnostic biomarker for multiple sclerosis (MS).
- Jun 2023Seed$1.2M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Madrid is moving
A read on the academic research around Biotechnology in Madrid — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 64 papers.
- Universidad Complutense de Madrid29
- Universidad Autónoma de Madrid23
- Universidad Politécnica de Madrid10
- Madrid Institute for Advanced Studies2
- Instituto de Ciencia de Materiales de Madrid2
- Bioassay1
- Toxoplasma gondii1
- Toxoplasmosis1
- Parasite hosting1
- Real-time polymerase chain reaction1
- Transcriptome3
- Gene3
- Essential oil2
- Mutant2
- Food science2
- Transcription (linguistics)2
- Messenger RNA2
- Transcriptome2
- Gene expression2
- Gene2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.